Bile acid metabolomics reveals distinct immunometabolic niches and enables accurate diagnosis of AQP4-IgG–seronegative NMOSD - Quiz - MDSpire

Bile acid metabolomics reveals distinct immunometabolic niches and enables accurate diagnosis of AQP4-IgG–seronegative NMOSD

  • By

  • Zixin Chen

  • Yuchen Ye

  • Yanping Lan

  • Kengna Fan

  • Xiaxia Qiu

  • Renquan Jiang

  • Xin Yang

  • Xinyao Yang

  • Xinrong Lu

  • Qunfang Huang

  • Yujue He

  • Can Liu

  • Qishui Ou

  • Zhen Xun

  • May 4, 2026

  • 0 min

Share

Original Source(s)

Bile acid metabolomics reveals distinct immunometabolic niches and enables accurate diagnosis of AQP4-IgG–seronegative NMOSD

  • by Zixin Chen, Yuchen Ye, Yanping Lan, Kengna Fan, Xiaxia Qiu, Renquan Jiang, Xin Yang, Xinyao Yang, Xinrong Lu, Qunfang Huang, Yujue He, Can Liu, Qishui Ou, Zhen Xun

  • May 4, 2026

Related Content

Oral BTK Inhibitor Shows Disability Benefit in Progressive Multiple Sclerosis Trial

Phase 3 results show fenebrutinib matched OCREVUS on disability progression in PPMS

  • February 17, 2026

  • 3 min
Analysis of the onset of lower urinary tract symptoms in multiple scleroris patients

Cladribine treatment in pediatric-onset multiple sclerosis: real-world clinical outcomes and safety insights